Bladder cancer is responsible for approximately 3% of all malignancies diagnosed in Australia each year. Bladder cancer is more common in men than women and typically affects people over 60 years of age.
Bladder cancer at an early stage of growth may not produce any noticeable signs or symptoms. Common signs of bladder cancer include haematuria (bloody urine that looks red or rusty), which is usually painless and may appear only from time to time over a period of months, a burning sensation during urination and a need to urinate often. It is important to note that these symptoms can also be characteristic of urinary tract infection.
When bladder cancer causes noticeable symptoms, these symptoms are usually related to the irritation brought about by tumour growth. Irritable symptoms include urination that is frequent, urgent, painful or difficult. These symptoms are more common among patients with ‘carcinoma in situ’ (CIS), cancer that has not spread and is still “in place”.
In fact, irritable urination (emptying of the bladder) may be the only noticeable symptom of CIS. Since irritable such symptoms also are caused by bacterial infections and kidney stones, it is essential to see your doctor to make an accurate diagnosis. A qualified doctor should evaluate any symptoms that last longer than 2 weeks.
If a bladder tumour blocks a ureter (one of the two tubes that pass urine out of the kidneys and into the bladder), patients may experience pain in the side of the body between the ribs and the top of the hip. In some cases, tumour growth may constrict the urethra (the tube that passes urine from the bladder out of the body) and slow the flow of the urine stream. Bladder cancers may also shed pieces of dead tissue, fragments of other tissue and other forms of tumour related matter that are then passed out with the urine.
If the tumour has spread beyond the bladder to surrounding tissue, the patient may experience pelvic pain. In addition, metastases from a bladder cancer may cause secondary symptoms, such as bone pain at the site of the new cancer or leg swelling (oedema) due to the involvement of the lymph nodes. Bladder cancer that has progressed to the point of organ invasion and metastases may eventually cause the patient to lose weight and feel fatigued. Anaemia and high blood levels of urea and other metabolic by-products, often due to urinary tract obstruction, may be further indications of late-stage bladder cancer.
If there is blood in the urine, or any of the other symptoms mentioned are experienced, your doctor will need to conduct some physical examinations in order to formulate an accurate diagnosis.
During a cystoscopy a thin flexible tube with a light and a camera lens is inserted into the urethra and up into the bladder, allowing the doctor to look at the inner lining of the bladder and check for any abnormalities or suspicious looking tissue. The doctor may also take a biopsy that can be examined more closely in a laboratory allowing an accurate diagnosis to be made.
Intravenous Pyelogram (IVP)
A special dye is injected your arm that travels through the bloodstream to the urinary tract, which in turn is then picked up through an x-ray. This process allows a doctor to see if there are any abnormalities in the bladder or urinary tract.
There are a number of possible treatments available to patients diagnosed with bladder cancer. These include Chemotherapy (see chemo information), Radiation Therapy and Surgery. A number of treatments may be used in conjunction with each other, typical examples being the use of pre-operative Radiation Therapy to shrink the tumour or slow its growth, or Intra-vesical therapies such as systemic chemotherapy.
The choice of treatments depend on a number of factors, including your age, general health and the extent and stage of the tumour. Discuss this with your doctor to ascertain the most appropriate course of treatment for you.
Bladder cancers that have grown into surrounding tissue usually require surgical therapy. Tumors that have invaded the muscle or tissue around the bladder need surgical management.
For women, a standard form of surgery is a Radical Cystectomy, which involves cutting away the entire bladder and associated tissues, with Pelvic Lymphadenectomy (removal of the lymph nodes within the hip cavity). Radical cystectomy in women includes removal of the uterus, Fallopian tubes, ovaries, anterior vaginal wall (the front of the birth canal), and urethra.
In men, a common surgical procedure is called a Cysto-Prostatectomy, which involves the removal of the bladder and prostate, with Pelvic Lymphadenectomy
Trans Urethral Resection of the Bladder Tumour (TURBT)
This procedure involves the inserting a thin tube, through the urethra and up into the bladder. The surgeon can then remove the tumour without the need for a large external excision
The body regulate its internal chemistry by passing blood through the kidneys, which then filter the blood and passing the wasted through the ureters into the bladder. This wasted is then discharged from the body in the form of urine.
Because some types of cancer can only be remedied by removing the bladder, another way must be found in order for the body to discharge urine. These procedures are called urinary diversions.
The most common diversion is called an Ileal Conduit – this involves taking a piece of bowel and forming a ‘pipe’ that is inserted where the bladder once was. The conduit then carries the urine from the ureters out onto the skin of the abdomen where the conduit ends in a Stoma – a small opening. Urine is then emptied into a plastic bag attached to the skin, where it can be emptied at various intervals.
Other forms of diversion involve the formation of an internal pouch made out of part of the bowel. The pouch has an inbuilt valve so that urine collects inside and does not leak through the Stoma. When it needs emptying, a small plastic tube called a Catheter can be passed through the stoma and the valve allowing urine to flow out. This is a major piece of surgery and requires much planning and recuperation time. The suitability of this procedure should be discussed with the Urologist.
Intra-vesical treatment involves flushing the bladder with chemotherapy or immunotherapy to flush out any residual tumour cells following surgery. Chemotherapy drugs are placed directly into the bladder in order to prevent the tumour recurring or to prevent it from invading the deeper layers of the bladder wall. Researchers have trialled various combinations of systemic drugs and a number of these have proven efficacy in the adjuvant treatment of bladder cancers.
Radiation Therapy for Bladder Cancer
What is Radiation Therapy?
Radiation therapy uses powerful x-rays and other high-energy rays to kill cancer cells using a machine called a ‘Linear Accelerator’. Damaging the cancer cells means that they cannot grow or multiply and so they die. Normal cells are also damaged in this procedure but usually recover.
Who gets Radiation Therapy?
A number of tests will be performed in order to allow doctors to determine the best course of treatment for each individual. The tests include a cystoscopy and a CT scan. These will show doctors the size of the tumour present and help determine whether radiation therapy is solely used or whether it can be used in conjunction with other treatments.
Before having radiation therapy a number of initial procedures need to be performed allowing doctors to specifically plan the best treatments for the type of cancer and the individual involved. This means that an accurate radiation dose to your cancer can be calculated while limiting the radiation to the surrounding areas such as the rectum.
CT scans are special x-rays that show the internal organs of your body. Dyes may also be injected allowing the doctor to see the area more clearly.
During treatment planning the radiation oncologist uses all the information gathered to develop an individual treatment plan.
What are the Side Effects?
The x-rays used during radiation therapy may damage normal body cells as well as cancer cells, although healthy cells usually recover from the damage. The incidence and severity of any side effects vary from patient to patient and may include
Tiredness or fatigue.
Bladder irritation, cramps or painful urination/blood in the urine.
Diarrhoea and Bowel Cramps.
Proctitis or pain in the rectum/bleeding.
A variety of measures can be taken to alleviate these symptoms, discuss these issues with your doctor and radiation therapy team for the best advice for each individual.
Robotic Bladder Cancer Surgery
The bladder is a hollow, muscular, elastic organ that stores urine, excreted by the kidney, before it is evacuated from the body by means of urination. Bladder cancer is a cancer affecting the tissues of the urinary bladder and is the second most common urologic cancer; after prostate cancer. It is malignant and can spread to other nearby organs, necessitating the need for partial or complete surgical removal of the bladder, which is the standard gold treatment approach for this cancer. Depending on the extent of spread, nearby lymph nodes and organs may also be removed along with the cancerous part of the bladder. In men, this may include removal of prostate, seminal vesicles and part of the vas deferens, while in women it may include the removal of cervix, uterus, ovaries, fallopian tubes and part of the vagina. This is a complex procedure but can be performed with precision and better control through a minimally invasive approach, using state of the art technology; robotic bladder cancer surgery.
Robotic bladder cancer surgery involves two machines, a control unit or the surgeon’s console and a patient unit. The surgeon sits at the control unit, away from the operating table, and controls the movement of the four robotic arms of the patient unit, present near the operating table. Robotic bladder cancer surgery allows the surgeon to visualize a highly magnified 3D view of the operation field, while sitting comfortably near a surgeon’s control unit. The high resolution images are transmitted to the control unit with the help of a camera held by a robotic arm, inserted through a small incision into the operation site. The surgeon then performs the surgery through tiny incisions using miniature endowrist instruments, held by the other three robotic arms of the patient unit.
The robotic arm cannot be programmed to do the surgery on its own. Instead, it translates the surgeon’s hand movements, at the control unit, into precise movements of the micro-instruments in the operation site, minimizing tremors that may occur from unintended shaking of the surgeon’s hands. The enhanced vision and superior control of the micro-instruments helps in precise removal of the bladder with less blood loss, less post operative pain, fewer complications, quicker recovery, shorter hospital stay, faster return to normal routine activities and a lower incidence of complications. It can also be used for bladder reconstruction techniques following the removal of bladder cancer.